Evidence map›Paper›PMID 41527210›Full record

ArticleMagnetic resonance in medicine2026

Motion- and Field-Robust Mesoscopic Whole-Brain

Matthias Serger, Rüdiger Stirnberg, Philipp Ehses, Malte Riedel, Thomas Ulrich, Caroline Le Ster, Franck Mauconduit, Vincent Gras, Alexis Amadon, Alexandre Vignaud and 6 more

Abstract read
In one paragraph

Article in Magnetic resonance in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Correcting motion-related BScientific reports · 2026
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Matthias SergerMR Physics, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.ORCID 0009-0009-4225-8986
Rüdiger StirnbergMR Physics, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.ORCID 0000-0001-7021-1063
Philipp EhsesMR Physics, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.ORCID 0000-0002-5839-6525
Malte RiedelInstitute for Biomedical Engineering, ETH Zurich and University of Zurich, Zurich, Switzerland.ORCID 0000-0002-5703-7408
Thomas UlrichInstitute for Biomedical Engineering, ETH Zurich and University of Zurich, Zurich, Switzerland.ORCID 0000-0003-1811-4295
Caroline Le SterCEA, CNRS, BAOBAB, NeuroSpin, University of Paris-Saclay, Gif sur Yvette, France.ORCID 0000-0002-4767-8738
Franck MauconduitCEA, CNRS, BAOBAB, NeuroSpin, University of Paris-Saclay, Gif sur Yvette, France.ORCID 0000-0002-0128-061X
Vincent GrasCEA, CNRS, BAOBAB, NeuroSpin, University of Paris-Saclay, Gif sur Yvette, France.ORCID 0000-0002-4997-2738
Alexis AmadonCEA, CNRS, BAOBAB, NeuroSpin, University of Paris-Saclay, Gif sur Yvette, France.ORCID 0000-0002-2667-9387
Alexandre VignaudCEA, CNRS, BAOBAB, NeuroSpin, University of Paris-Saclay, Gif sur Yvette, France.ORCID 0000-0001-9203-0247
Son ChuImaging Centre of Excellence, University of Glasgow, Glasgow, UK.ORCID 0000-0002-4170-777X
Shajan GunamonyImaging Centre of Excellence, University of Glasgow, Glasgow, UK.ORCID 0000-0002-3146-6079
Maxim ZaitsevDivision of Medical Physics, Department of Diagnostic and Interventional Radiology, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.ORCID 0000-0001-7530-1228
Nicolas BoulantCEA, CNRS, BAOBAB, NeuroSpin, University of Paris-Saclay, Gif sur Yvette, France.ORCID 0000-0003-2144-2484
Klaas P PruessmannInstitute for Biomedical Engineering, ETH Zurich and University of Zurich, Zurich, Switzerland.ORCID 0000-0003-0009-8362
Tony StoeckerMR Physics, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.ORCID 0000-0002-8946-9141

Funding

Agence Nationale de la Recherche (ANR) ANR-21-ESRE-0006Horizon 2020 Framework Programme 885876
6 · The paper itself

Abstract

purposeTo mitigate artifacts related to motion and field changes in high-resolution

methodsMR-based servo navigators were integrated into a segmented 3D-EPI sequence to allow for prospective correction of involuntary head motion and first-order shim changes. Seven subjects were scanned with whole-brain protocols at 0.3 mm isotropic resolution with and without correction at 7 and 11.7 T. Validation was performed on detailed brain vasculature in scans with involuntary motion.

resultsBlurring of small veins was reduced by servo navigation for all subjects and across field strengths. In case of involuntary large motion, the method preserved image quality, while uncorrected motion led to severe artifacts. In case of microscopic motion, reduced blurring and shading in the frontal lobe demonstrate the additional benefit of prospective field drift correction.

conclusionServo-navigated segmented 3D-EPI improves 0.3 mm isotropic whole-brain

Indexed as

BrainEcho-Planar ImagingImage Processing, Computer-AssistedImaging, Three-DimensionalMagnetic Resonance ImagingAdultAlgorithmsArtifactsFemaleHumansImage EnhancementMaleMotion11.7 T3D‐EPIbrain vasculaturemesoscopic imagingprospective motion correctionservo navigation

Identifiers

PMID41527210
PMCPMC12962216

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.